0 items USD 0.00Search
Your search for "mrrpb5 global car t cell therapy multiple myeloma market size status forecast 2019 2025" gave back 1521283 results.
Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable;...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Gamma Secretase - Pipeline Review, H2 2020 Summary According to the recently published report 'Gamma Secretase - Pipeline Review, H2 2020...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
20s Proteasome - Drugs in Development, 2021 Summary 20s Proteasome pipeline Target constitutes close to 9 molecules. Out of which approximately 6...
Catalog:
Global Markets Direct
September 2021
Price: USD 3,500.00
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Exportin 1 - Pipeline Review, H2 2019 Summary According to the recently published report 'Exportin 1 - Pipeline Review, H2 2019'; Exportin...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
The global Hematologic Malignancies Treatment market size was valued at USD 55000 million in 2023 and is forecast to a readjusted size of USD 221510...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Gamma Secretase - Pipeline Review, H1 2020 Summary According to the recently published report 'Gamma Secretase (EC 3.4.23.) - Pipeline Review,...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
20s Proteasome - Pipeline Review, H2 2020 Summary According to the recently published report '20s Proteasome - Pipeline Review, H2 2020';...
Catalog:
Global Markets Direct
November 2020
Price: USD 3,500.00
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
Catalog:
La Merie Publishing
July 2022
Price: USD 2,000.00
Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,500.00
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing...
Catalog:
LPI
January 2023
Price: USD 3,660.00
20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary 20s Proteasome - 20S proteasome...
Catalog:
Global Markets Direct
September 2022
Price: USD 3,500.00
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 - Pipeline Review, H2 2019 Summary Induced Myeloid Leukemia Cell Differentiation Protein...
Catalog:
Global Markets Direct
August 2019
Price: USD 3,500.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Latin America (4) Apply Latin America filter
- Middle East (3) Apply Middle East filter
- Africa (2) Apply Africa filter
- America (1) Apply America filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
